Epidermolysis bullosa simplex (EBS) is an autosomal dominant disorder characterised by intraepidermal blistering of the skin. Two families with Weber-Cockayne EBS have been analysed for linkage to keratin gene loci. In the first family, linkage was found to chromosome 17 markers flanking the keratin 14 gene (Dl 7S74: Zmax = + 2 45, 0= 0-10; COLIAI: Zmax = + 0 97, 0 = 0 00) and markers near the keratin 5 gene on chromosome 12 were excluded (D12S1 7: Z < -2-0, 0 = 0-08; COL2A1: Z< -2'0, 0=0413). In contrast, the second family showed linkage to the region containing the keratin 5 gene (D12S17: Zmax = + 1P37, 0 = 0-08; COL2A1: Zmax= + 0 33, 0= 0 15) and was not linked to the keratin 14 gene (D17S74: Z< -2'0, 0= 0 14). The Weber-Cockayne form of EBS is genetically hetergeneous with linkage to different keratin gene loci.
These basal cell keratins are encoded by keratin gene clusters on chromosomes 17 and 12 respectively. 17 18 There is now considerable evidence to implicate the keratin genes in the pathogenesis of EBS. In all forms of EBS cytolysis occurs in the basal layer of the epidermis and there is abnormal keratin intermediate filament formation.s7 Transgenic mice expressing a mutant K14 gene also develop these features of the disease.3 Different point mutations have been found within the K14 gene in two patients with EBS-DM19 and a third point mutation in this gene has also been identified in a family with EBS-K.20 Recently, a family with EBS which was initially generalised and subsequently mainly localised to the hands and feet has shown linkage to loci near the K5 gene.2'
One family with EBS-WC is also reported to be linked to this region. 20 We have found one family with EBS-WC affecting the hands and feet linked to the keratin 14 gene on chromosome 17 . This is the first report of a family with EBS-WC showing linkage to this locus. Our second family with disease confined to the feet shows probable linkage to the region of the keratin 5 gene on chromosome 12. We hope to elucidate the nature of the mutations responsible for the disease in these two families.
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